By analyzing available public GBM datasets from the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), we revealed that FOSL2 was highly expressed in mesenchymal GBM (Supplementary Fig. S4A–D), which was consistent with the expression characteristics of RUNX1. This evidence concerns the gene FOSL2 and central nervous system cancer.